New LiDCO Monitors (AIM:LID) chosen by Intel for OPTIMISE case study

Tuesday, Feb 02 2010 by

iStock_000007955764XSmall.jpgLidco Group, the cardiovascular monitoring company, announced today that its LiDCOrapid Monitor has been featured in a case study from  Intel, world leader in silicon chip innovation. The trial is reported to be the largest of its kind in the world to date.

The AIM-listed LiDCO group was established in 1991 by Dr Terry O'Brien, Dr David Band, Dr Robert Linton and Dr Jiri Kratochvil in collaboration with the United Dental and Medical Schools of St Thomas' and Guys Hospitals (now King's College, London.) Since that time, the Group has specialised in cardiovascular monitoring. 

The LiDCOrapid Monitor uses Intel’s processing chips within terminals provided by Advantech to provide physicians with information on the patient’s fluid and cardiovascular status during surgery  or while in intensive care. According the the announcement, these monitors are fully compliant with all medical related technology standards, and ‘lead the way in terms of display, performance and power consumption’.  

Users of the new technology include OPTIMISE, a government-supported multi-centre trial in the UK, which aims to improve surgical outcomes by optimising patient's cardiovascular management. 

Dr Terry O'Brien, CEO of LiDCO, commented:  

"I am delighted that Intel has recognised LiDCO as an innovative and leading technology developer in the medical sector. We place a high emphasis on performance and quality; our ongoing relationship with Intel and Advantech allow us to deliver cutting edge technology cost effectively.  To be acknowledged in this case study for our innovation and having the product of that collaboration, the LiDCOrapid, chosen as the sole technology for the OPTIMISE study is a great honour for us."

The case study is available on Intel's website.  



Filed Under: Heart, Optimise, Intel, Cardiovascular,
There's value in the stock market
but do you know where to look?

Get the most concise synopsis of everything that's been proven to work in value investing. If you like your stocks cheap you've found a treasure trove distilled to under 70 pages.

  • How to find ultimate Bargain Stocks with Ben Graham
  • How to spot Turnarounds and avoid Value Traps
  • From Graham to Greenblatt via Piotroski & Lakonishok
  • How to value stocks and set a margin of safety

Soon to be retailing for an RRP of £14.99, for a limited time only,
you can get your copy free by joining our 35,000 strong mailing list.

*By signing up you'll be joining our mailing list
no junk, no spam - just great content like this example.


Disclaimer:  

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.


Do you like this Post?
Yes
No
0 thumbs up
0 thumbs down
Share this post with friends



LiDCO Group PLC supplies hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. The Company’s principal activity is the development, manufacture and sale of cardiac monitoring equipment. Its products enable the measurement, analysis, audit, training and sharing of real-time and historic hemodynamic data. The Company’s products include LiDCOplus a computer-based platform monitor used in the intensive care unit for real-time continuous display of hemodynamic parameters; LiDCOrapid, which is a cardiac output monitor; LiDCOview, which gives a graphical display of LiDCOplus and LiDCOrapid, and LiDCOrapidv2 with Unity software, which is a monitor designed for multi-parameter monitoring of both depth of anesthesia and fluids. more »

Share Price (AIM)
11.25p
Change
 
Mkt Cap (£m)
21.8
P/E (fwd)
19.2
Yield (fwd)
n/a



  Is Lidco fundamentally strong or weak? Find out More »


What's your view on this news? Log In to Comment Now

You can track all @StockoChat comments via Twitter


About Stockopedia News

Stockopedia News

Stockopedia News Bulletins aim to report on stories and companies that are relevant to and popular with online investors.  It's a free service provided to registered users of Stockopedia. 



Stock Picking Tutorial Centre



Stock Picking Simplified

Stockopedia takes your stock picking to the next level with cutting edge Stock Reports & Screening tools.


Get started
or Take a Tour to find out more.